BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17208142)

  • 1. Surgical benchmarks for the treatment of invasive bladder cancer.
    Skinner EC; Stein JP; Skinner DG
    Urol Oncol; 2007; 25(1):66-71. PubMed ID: 17208142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report.
    Herr H; Lee C; Chang S; Lerner S;
    J Urol; 2004 May; 171(5):1823-8; discussion 1827-8. PubMed ID: 15076285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard.
    Raj GV; Bochner BH
    Semin Oncol; 2007 Apr; 34(2):110-21. PubMed ID: 17382794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer.
    Bruins HM; Stein JP
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1091-101. PubMed ID: 18588454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node dissection for bladder cancer: the issue of extent and feasibility in the minimally invasive era.
    Ghavamian R; Hakimi AA
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1783-92. PubMed ID: 19954290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open radical cystectomy with lymphadenectomy remains the treatment of choice for invasive bladder cancer.
    Huang GJ; Stein JP
    Curr Opin Urol; 2007 Sep; 17(5):369-75. PubMed ID: 17762633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of provider volume on outcomes from urological cancer therapy.
    Joudi FN; Konety BR
    J Urol; 2005 Aug; 174(2):432-8. PubMed ID: 16006859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphadenectomy in bladder cancer: a review.
    Buscarini M; Josephson DY; Stein JP
    Urol Int; 2007; 79(3):191-9. PubMed ID: 17940349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients.
    Canter D; Guzzo TJ; Resnick MJ; Bergey MR; Sonnad SS; Tomaszewski J; VanArsdalen K; Malkowicz SB
    Urology; 2009 Jul; 74(1):161-5. PubMed ID: 19371932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic and staging value of lymph node dissection in the treatment of invasive bladder cancer.
    Sanderson KM; Skinner D; Stein JP
    Nat Clin Pract Urol; 2006 Sep; 3(9):485-94. PubMed ID: 16964190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robotic-assisted laparoscopic radical cystoprostatectomy.
    Pruthi RS; Wallen EM
    Eur Urol; 2008 Feb; 53(2):310-22. PubMed ID: 17400365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer Institute.
    Guru KA; Kim HL; Piacente PM; Mohler JL
    Urology; 2007 Mar; 69(3):469-74. PubMed ID: 17382147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic radical cystectomy for cancer: oncological outcomes at up to 5 years.
    Haber GP; Gill IS
    BJU Int; 2007 Jul; 100(1):137-42. PubMed ID: 17552961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic assisted laparoscopic radical cystoprostatectomy: operative and pathological outcomes.
    Pruthi RS; Wallen EM
    J Urol; 2007 Sep; 178(3 Pt 1):814-8. PubMed ID: 17631334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results.
    Mills RD; Fleischmann A; Studer UE
    Surg Oncol Clin N Am; 2007 Jan; 16(1):233-45. PubMed ID: 17336246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital lymph node counts and survival after radical cystectomy.
    Hollenbeck BK; Ye Z; Wong SL; Montie JE; Birkmeyer JD
    Cancer; 2008 Feb; 112(4):806-12. PubMed ID: 18085612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does extended lymphadenectomy preclude laparoscopic or robot-assisted radical cystectomy in advanced bladder cancer?
    Schumacher MC; Jonsson MN; Wiklund NP
    Curr Opin Urol; 2009 Sep; 19(5):527-32. PubMed ID: 19553823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.